Two new studies demonstrate the impact of respiratory syncytial virus (RSV) in different populations, with one showing that ...

Respiratory syncytial virus (RSV) infections were associated with significantly increased risk for complications beyond ...

The CDC already recommends the RSV shot for all adults 75 and older and for people 60 and older who have health conditions that increase their risk of severe RSV. It also recommends the shot during ...

In April, the CDC’s influential Advisory Committee on Immunization Practices recommended expanding RSV vaccination to ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

Vaccination programs have saved lives – and saved the Canadian economy and health care system significant resources as well ...

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The medicines regulator has flagged up a small increased risk of Guillain-Barré syndrome after RSV vaccination in adults over ...

Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...

Respiratory syncytial virus, or RSV, is usually mild but can cause severe illness in infants, older adults and people with certain health problems. It affects the nose, throat and lungs.